|
注册号: Registration number: |
ChiCTR2300078531 |
|
最近更新日期: Date of Last Refreshed on: |
2023-12-12 09:00:01 |
|
注册时间: Date of Registration: |
2023-12-12 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
针刺联合人体生物刺激反馈治疗失眠的临床研究 |
|
Public title: |
Clinical study of acupuncture combined with human biostimulatory feedback in the treatment of insomnia |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
针刺联合人体生物刺激反馈治疗失眠的临床研究 |
|
Scientific title: |
Clinical study of acupuncture combined with human biostimulatory feedback in the treatment of insomnia |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
丁贵斌 |
研究负责人: |
丁贵斌 |
|
Applicant: |
Ding Guibin |
Study leader: |
Ding Guibin |
|
申请注册联系人电话: Applicant telephone: |
+86 135 6346 0021 |
研究负责人电话:
Study leader's |
+86 135 6346 0021 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
guibin211@126.com |
研究负责人电子邮件: Study leader's E-mail: |
guibin211@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
山东省济南市历城区唐冶街道围子山路3126号 |
研究负责人通讯地址: |
山东省济南市历城区唐冶街道围子山路3126号 |
|
Applicant address: |
No.3126, Weizishan Road, Tangye Street, Licheng District, Jinan City, Shandong Province |
Study leader's address: |
No.3126, Weizishan Road, Tangye Street, Licheng District, Jinan City, Shandong Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
山东省康复医院 |
||
|
Applicant's institution: |
Shandong Rehabilitation Hospital |
||
|
研究负责人所在单位: |
山东省康复医院 |
||
|
Affiliation of the Leader: |
Shandong Rehabilitation Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(科)伦审第2023(20)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
山东省康复医院伦理委员会 |
||
|
Name of the ethic committee: |
Shandong Rehabilitation Hospital Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-11-02 00:00:00 | ||
|
伦理委员会联系人: |
郭玲玲 |
||
|
Contact Name of the ethic committee: |
Guo Lingling |
||
|
伦理委员会联系地址: |
山东省济南市历城区唐冶街道围子山路3126号 |
||
|
Contact Address of the ethic committee: |
No.3126, Weizishan Road, Tangye Street, Licheng District, Jinan City, Shandong Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 134 6517 2525 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
山东省康复医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shandong Rehabilitation Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
山东省济南市历城区唐冶街道围子山路3126号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.3126, Weizishan Road, Tangye Street, Licheng District, Jinan City, Shandong Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自选项目(自筹) |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-selected project (self-funded) |
||||||||||||||||||||||
|
研究疾病: |
失眠 |
||||||||||||||||||||||
|
Target disease: |
insomnia |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本课题旨在探讨针刺联合人体生物刺激反馈治疗失眠的临床效果,比较针刺联合人体生物刺激反馈和人体生物刺激反馈治疗失眠的疗效差异以及对失眠患者焦虑、抑郁症状的改善情况,以期为失眠患者提供有效的治疗方法,改善患者的睡眠质量,缓解抑郁和焦虑症状,提高患者的生活质量,为临床治疗失眠提供更多的参考依据和治疗手段。 |
||||||||||||||||||||||
|
Objectives of Study: |
The purpose of this study is to explore the clinical effect of acupuncture combined with human biostimulation feedback in the treatment of insomnia, compare the difference in the efficacy of acupuncture combined with human biostimulation feedback and human biostimulation feedback in the treatment of insomnia, and improve the anxiety and depression symptoms of insomnia patients, so as to provide effective treatment methods for insomnia patients, improve the sleep quality of patients, and alleviate depression and anxiety symptoms. Improve the quality of life of patients and provide more reference and treatment means for clinical treatment of insomnia. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
①对针刺有禁忌者。 ②患有严重基础性疾病(如:肾衰、心衰等)者。 ③存在生命体征不稳、失聪、痴呆、认知障碍、失语等无法正常交流者。 ④合并有其他精神类疾病的患者。 ⑤安装心脏起搏器患者及孕妇。 |
||||||||||||||||||||||
|
Exclusion criteria: |
① There is a taboo against acupuncture. ② Suffering from serious basic diseases (such as: kidney failure, heart failure, etc.). ③ Patients with unstable vital signs, deafness, dementia, cognitive impairment, aphasia and other difficulties in normal communication. ④Patients with other mental diseases. ⑤ Patients with cardiac pacemakers and pregnant women. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-11-01 00:00:00至 To 2024-12-28 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-12-12 00:00:00 至 To 2024-10-12 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
将招募进本课题组的60例失眠患者按照随机数字表法分为两组,实验组30例接受针刺联合人体生物刺激反馈治疗,对照组30例接受人体生物刺激反馈治疗。随机分组,按照数字(1-60)从小到大的顺序随机进行编号,序号为奇数的纳入试验组,序号为偶数的纳入对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The 60 insomnia patients enrolled in this research group were divided into two groups according to the random number table method. 30 patients in the experimental group received acupuncture combined with human biostimulation feedback treatment, and 30 patients in the control group received human biostimulation feedback treatment. The group was randomly assigned according to the order of numbers (1-60) from small to large. The odd serial number was included in the experimental group, and the even serial number was included in the control group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
所有受试者将在治疗开始前、治疗过程中以及治疗结束后接受失眠、抑郁和焦虑的评价。这些评价将采用国际通用的量表进行,如匹兹堡睡眠质量指数( PSQI) 、睡眠状况自评量表(SRSS)、焦虑自评量表( SAS)、抑郁自评量表( SDS)。通过对比试验组和对照组在各个评价时间点的得分,能够了解针刺联合人体生物刺激反馈治疗对失眠的疗效。应用SPSS22.0统计软件对数据进行处理,均数比较采用t检验,计数资料采用X2检验,P<0.05认为差异有统计学意义。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
All subjects will be evaluated for insomnia, depression, and anxiety before, during, and after treatment. These assessments will be conducted using internationally accepted scales such as the Pittsburgh Sleep Quality Index (PSQI), Self-Rating Sleep Status Scale (SRSS), Self-Rating Anxiety Scale (SAS), and Self-Rating Depression Scale (SDS). By comparing the scores of the experimental group and the control group at each evaluation time point, we can understand the effect of acupuncture combined with human biostimulation feedback treatment on insomnia. SPSS22.0 statistical software was used to process the data. t test was used for comparison of mean numbers and X2 test was used for counting data. P < 0.05 was considered statistically significant. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |